Get in touch with the right contacts for all of our services.
National Cancer Institute Awards $1.2M for Nemours Community Clinical Oncology Program
Second pediatric consortium of its kind in U.S.
Eric Sandler, MD
The Nemours Center for Cancer and Blood Disorders has received a 2-year $1.2 million grant from the National Cancer Institute (NCI) of the National Institute of Health (NIH), to establish the Nemours Community Clinical Oncology Program (CCOP). Eric Sandler, MD and E. Anders Kolb, MD, Principal Investigator and Associate Principal Investigator, respectively, will lead the initiative. Noteworthy as only the second pediatric CCOP in the country, the consortium brings together four Nemours sites and several cancer investigators in an integrated pediatric cancer network.
E. Anders Kolb, MD
The sites are:
- Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE
- Nemours Children’s Specialty Care, Jacksonville, FL
- Nemours Children’s Hospital, Orlando, FL
- Nemours Children’s Specialty Care, Pensacola, FL
The formation of a pediatric CCOP is uncommon, given that pediatric cancer is relatively rare and therefore enrolling patients in significant numbers for studies can be challenging. Alignment of the four programs will enable greater enrollment and increase access to pediatric clinical oncology trials, particularly for a diverse population. The potential for positive impact is great given Nemours’ institutional commitment, capable leadership and investigative team, highly supportive research environment and consortium-wide access to patient records and clinical trial data.
The prestigious award positions Nemours for future participation in the NCI Community Oncology Research Program. It is recognition of the oncology programs across the Nemours enterprise and reflects an ongoing commitment to advancing new cancer treatments, focused on a family-centered approach that includes consideration of psychosocial and other needs to reduce stress and improve outcomes.
Dr. Sandler, who is Division Chief of Hematology/Oncology in Jacksonville, Fla., said now that the four sites are linked, “it’s a tremendous opportunity not only to take excellent care of kids as we already do, but to develop a more integrated program. We can look at our science together and help each other.” Dr. Sandler and co-investigator, Dr. Kolb, Director of the Center for Cancer and Blood Disorders at duPont Hospital for Children, will also meet regularly with the other sites to collaborate.